Neutrophil-to-Lymphocyte Ratio as a Prognostic Marker for Anaplastic Thyroid Cancer Treated With Lenvatinib

Conclusion: The baseline NLR is a potential prognostic marker, and the change of NLR can be an early indicator of response for ATC patients treated with lenvatinib.

Source: In Vivo - August 30, 2020 Category: Research Authors: FUKUDA, N., TODA, K., FUJIWARA, Y., WANG, X., OHMOTO, A., URASAKI, T., HAYASHI, N., SATO, Y., NAKANO, K., YUNOKAWA, M., ONO, M., TOMOMATSU, J., MITANI, H., TAKAHASHI, S. Tags: Clinical Studies Source Type: research